Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

1994581 citationsJournal Articlebronze Open Access

Authors

W. C. Wood · Emory University

Daniel R. Budman · North Shore University Hospital

Ann H. Korzun · Harvard University

M. Robert Cooper · Wake Forest University

Jerry Younger · Massachusetts General Hospital

Ronald D. Hart · Aurora St. Luke's Medical Center

Anne Moore · NewYork–Presbyterian Hospital

Abstract

The doses of chemotherapy used to treat breast cancer, especially early breast cancer, should not be reduced if the maximal benefit is to be achieved.

Topics & Keywords

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Medical Imaging Techniques and Applications

Publication Details

Published in: New England Journal of Medicine

Volume 330, Issue 18, pp. 1253-1259

DOI: 10.1056/nejm199405053301801

Field-Weighted Citation Impact: 18.57

Command Palette

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

Authors

Abstract

Topics & Keywords

Publication Details